Planning and Evaluation Core

规划与评估核心

基本信息

批准号：
8322843
负责人：
Gabriel Lopez-Berestein
金额：
$ 6.63万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-09-01 至 2013-08-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8322843
关键词：
Applications Grants Area Basic Science Cancer Center Clinical Clinical Cancer Center Clinical Research Clinical Trials Collaborations Commit Communities Community Clinical Oncology Program Development Diagnostic Doctor of Philosophy Effectiveness Ensure Evaluation Faculty Fostering Funding Goals Grant Hospitals Information Dissemination Inpatients Island Link Malignant Neoplasms Manuscripts Mission Monitor National Cancer Program Outpatients Patients Personnel Recruitments Pharmacologic Substance Phase Phase II Clinical Trials Phase III Clinical Trials Population Process Puerto Rico Recruitment Activity Research Research Activity Research Infrastructure Research Personnel Research Project Grants Structure Students System Tissues Training Training Programs Training and Education Translational Research United States National Institutes of Health University of Texas M D Anderson Cancer Center Update Visit Work anticancer research cancer health disparity interest member outreach outreach program programs symposium treatment center tumor registry virtual web site

项目摘要

To sustain the high quality of research expected from this Partnership, strict planning and evaluation processes have been implemented to monitor collaboration building, as well as all projects, programs and cores against both the Partnership's mission, goals and objectives, and the mission, goals and objectives of the U54 mechanism itself, It is our intent to utilize Partnership funding for projects and programs to nurture their development, but not to provide long-term support. As a part of building and sustaining excellence, all projects and programs undergo a strenuous review by our internal and external committees (Table 38) and are expected to (and must develop a plan to) apply for external funding from the NIH or an equivalent agency. These planning and evaluation processes are also instrumental in accurately assessing the Partnership's effectiveness towards achieving its immediate (1-3 years) and intermediate (4-5 years) goals (See Section 1.5) of establishing a sustainable research infrastructure (e.g., key personnel recruitment, clinical accrual cores, tissue cores, assigned building space, and further defining programmatic approaches toward the development of the roadmap to obtain cancer center designation) at the UPRCCC. Not to mention, strategically, a strong ¿ planning and evaluation process is needed to aid the Partnership in achieving its long-term goal (post-U54 funding) of regaining NCI-designation for the UPRCCC. Although regaining NCI-designation is not a direct goal within the scope of the U54 mechanism, as Pis, we believe that it is imperative for us to not just think in terms of U54 specifics, but to pursue goals beyond the U54. For us, regaining NCI-designation is a positive step towards building a stronger national cancer program aimed at understanding the reasons behind cancer health disparities and their impact on the populations we serve.

为了维持合作伙伴关系的高质量研究，严格的计划和评估流程已实施以监视协作建设以及所有项目，计划和核心伙伴关系的使命，傻瓜和目标，以及U54的使命，目标和目标机制本身，我们的意图是利用合伙资金来进行项目和计划来培养其发展，但不提供长期支持。程序进行了我们的内部和外部委员会的剧烈评论（表38），并且是期望（并且必须制定计划）申请NIH或同等机构的外部资金。这些计划和评估过程也有助于评估合作伙伴关系有效实现其即时（1 - 3年）和国际（4 - 5年）的目标（请参阅第1.5节）建立可持续研究基础设施（例如，关键人员招聘，临床应计核心，组织内核，分配建筑空间，并进一步定义开发的程序化方法在UPRCCC上获得癌症中央的路线图。挥之不去需要计划和评估过程来帮助实现其长期目标（U54后恢复UPRCC的NCI设计的资金。在U54机制范围内的目标，作为PI，我们认为，我们必须不仅仅是仅仅考虑U54的细节，但要追求U54以外的目标。是迈向建立更强大的国家癌症计划的积极一步，旨在了解您癌症健康差异的原因以及对我们服务人群的影响。